Hair Thinning and Hair Loss in Midlife Women
Scalp hair commonly thins during perimenopause and menopause. The causes are multiple, the workup matters, and a careful approach is both safer and more effective than a single off-the-shelf product.
This article is educational and is not medical advice. Consult your clinician before starting, stopping, or changing hormone therapy. Individual responses to HRT vary; the right hormones, doses, and delivery methods for you depend on your medical history and clinical context.
The common pattern
The most common pattern in midlife women is diffuse thinning over the top and crown of the scalp, often most noticeable at the part, with the frontal hairline relatively preserved. This is consistent with female-pattern hair loss (androgenetic alopecia), which has a hormonal component that can become more clinically apparent as estradiol declines and the relative androgen effect on the scalp rises.
What actually deserves a workup first
Before any treatment is started, a thoughtful clinician will rule out non-hormonal contributors that frequently coexist in midlife women:
- Iron deficiency (ferritin, not just hemoglobin)
- Thyroid dysfunction
- Vitamin D deficiency
- Recent significant weight loss or low protein intake
- A recent major stressor producing telogen effluvium (a shedding pattern that resolves on its own)
- Scalp conditions (seborrheic dermatitis, lichen planopilaris)
- Medications that contribute to hair loss
Several of these are easily missed and are reversible. Treating androgenetic alopecia without addressing a coexisting iron deficiency, for example, underperforms what would have been possible with the workup done first.
What the evidence supports for treatment
- Topical minoxidil — the strongest non-prescription evidence base for female-pattern hair loss.
- Low-dose oral minoxidil — used off-label with growing evidence; requires clinician oversight for blood pressure and side-effect considerations.
- Spironolactone — an anti-androgen used off-label for female-pattern hair loss, with reasonable evidence in the right patient.
- HRT — has not been shown to be a primary treatment for hair loss, but addressing the broader hormonal picture can help indirectly.
Where to start
For midlife women whose hair complaint is part of a broader perimenopausal picture, one of the comprehensive-care telehealth practices that can coordinate HRT with adjacent prescribing (Alloy in particular) is usually a better starting point than a standalone hair-loss service. For patients with isolated androgenetic alopecia and no broader symptom picture, a dermatology-led practice will go deeper on the workup. See the provider comparison for trade-offs.